Protectimmun GmbH has successfully closed a first financing round totalling EUR 1.3 Million. Hightech-Gründerfonds (HTGF), ELS-Fonds managed by EnjoyVenture, and KfW invest in the innovative approach for protection against the development of hay fever and allergic asthma together with a private investor and the team of founders.
 
“We are very pleased to get these experienced partners on board, says Dr. Marion Kauth, CEO and co-founder of Protectimmun.”This financing enables us to rapidly proceed with the preclinical testing and to prepare for clinical studies. In addition, we gain access to a well-organised network with important new contact opportunities that may facilitate further business development.”

Kanzlei Dr. Huhmann, a Düsseldorf based legal office and specialised in corporate law and private equity/venture capital transactions, acted on behalf of enjoy venture Management GmbH, representing ELS Fonds GmbH & Co. KG.

info@kanzlei-huhmann.de